Literature DB >> 33979234

Cost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: it is time for evidence based economic evaluations.

Alois Gratwohl1.   

Abstract

Entities:  

Year:  2021        PMID： 33979234     DOI： 10.1080/13696998.2021.1929259

Source DB:  PubMed          Journal:  J Med Econ        ISSN： 1369-6998            Impact factor:   2.448


× No keyword cloud information.
  1 in total

1.  Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.

Authors:  Lina Stutz; Jörg P Halter; Dominik Heim; Jakob R Passweg; Michael Medinger
Journal:  Bone Marrow Transplant       Date:  2022-01-04       Impact factor: 5.174
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.